Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Astrazeneca Announces sBLA For Imfinzi Plus EV Granted Priority Review In US For MIBC

    Picture of AstraZeneca logoAstraZeneca
    25/09/2026 07:13
    BRIEF-Astrazeneca Announces sBLA For Imfinzi Plus EV Granted Priority Review In US For MIBC
    Sept 25 (Reuters) - AstraZeneca PLC AZN.L:
    • PERIOPERATIVE IMFINZI PLUS NEOADJUVANT ENFORTUMAB VEDOTIN GRANTED PRIORITY REVIEW IN THE US FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    • ASTRAZENECA - FDA ACTION DATE FOR ASTRAZENECA S BLA ANTICIPATED IN Q4 2026
    Source text: ID:nWkrFHWys
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com))

    Recent news on AstraZeneca

    See all news